The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 12,416.00
Ask: 12,418.00
Change: 44.00 (0.36%)
Spread: 2.00 (0.016%)
Open: 12,330.00
High: 12,450.00
Low: 12,316.00
Prev. Close: 12,360.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Value calls vindicated in August

Tue, 01st Sep 2020 13:00

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com)
and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) in Milan.

VALUE CALLS VINDICATED IN AUGUST (1159 GMT)

The rising calls to invest in 'value' these last three months have often been met with a
fair whack of scepticism given the awful performance of that investment style in 2020 and the
irresistible surge of Fangs and tech.

Yet, trading in August has pretty much vindicated those who believed that, like they've
often done in the past, rising markets would progressively lift up cheap laggards as the
economic recovery gradually unfolds.

In its dashboard for August, S&P Dow Jones Indices shows how value in Europe outperformed
rival investment styles with a 6.3% monthly rise and a 9.7% jump over the last three months.

Year-to-date though, it's still a 29% fall, which probably means that value ain't causing
that much FOMO so far this year in comparison with say... buying a position in Apple or Tesla!

Here's the S&P Dow Jones Indices Dashboard for Europe:

More on the value theme these last few weeks:

LIVE MARKETS-Value sirens singing the blues

LIVE MARKETS-Actually, talking about value...

LIVE MARKETS-Another value call

LIVE MARKETS-Does U.S. election mean rotation towards value?

LIVE MARKETS-The value value-trap

LIVE MARKETS-Is it value stocks' time?

(Julien Ponthus)

*****

MORE CONCERNS ON SOUTHERN EUROPEAN BANKS (1012 GMT)

Policy response from governments and the European central bank has been strong, the EU
Recovery fund was a major milestone supporting the sector, but most Southern Europe bank shares
are already fully valued, according to some analysts.

Today Europe’s banks are down 1.7%, while the STOXX 600 index is flat with the tech sector
leading gains up 1.5%.

“We would argue the 'value' argument across some names is now is less clear-cut,” a
Jefferies research report says.

The main issue is the economic impact of the second wave of coronavirus infections which has
hit Europe as “the mid-term outlook remains challenged and, despite some pick-up in inflation
expectations, Euribor rates and futures continue to move lower,” it adds.

“While we are broadly aligned with consensus profit expectations in 2022 (on average), we
sit around 10% below consensus on 2022 pre-provision numbers which tempers our enthusiasm.”

Jefferies top picks are Intesa Sanpaolo, Caixabank and Bankia, while the
broker continues to like Unicaja.

(Stefano Rebaudo)

*****

STOXX 600 DOWN? BLAME THE BRITS! (0912 GMT)

There's no need to beat around the bush: if the STOXX 600 is slightly down (-0.1%) this
morning it's all because of London-listed stocks.

Quite striking how the first 32 losers on the pan-European index are ALL London-listed:

As put by AJ Bell analyst Russ Mould, the FTSE "was nursing a hangover after the Bank
Holiday" and was down over 1.3%.

"Not helping the FTSE’s cause was strength in sterling relative to the dollar, a currency
move which impacts the relative weight of the overseas earnings which dominate the index", Mould
added.

Looking at other European bourses, Germany's DAX is doing quite well, up 0.4% and Milan's
FTSE MIB is still in positive territory.

But looking at 2020 so far this year, the underperformance of the FTSE 100 is becoming a key
feature of the COVID-19 vintage.

Here's the FTSE 100 (blue) against the EURO STOXX 50 and the S&P 500:

(Julien Ponthus)

*****

OPENING SNAPSHOT: TECH AND HEALTH CARE SECTORS LEAD GAINS (0728 GMT)

Tech shares, particularly iPhone suppliers, are leading gains in the European stock market
after a press report that Apple Inc has asked suppliers to make at least 75 million 5G
iPhones for later this year, along with new Apple Watch models, a new iPad Air and a smaller
HomePod.

Among Apple suppliers Dialog Semi stocks are up 2.2%, STMicro shares rise
1%, Infineon shares up 1.6%.

The STOXX 600 index is up 0.7% with the tech sector up 1.5%. The healthcare sector is rising
1.2% after AstraZeneca said they could have data to ask U.S. emergency use authorization
or approval of their COVID-19 vaccines in the short term.

Risk sentiment is supported by a strong survey from China, while concerns about pandemic
trajectories continue to weigh. Travel and leisure stocks are the worst performers
sliding 1%, banks continue to lag behind, down 0.2%.

(Stefano Rebaudo)

*****

ON THE RADAR: ASTRAZENECA, APPLE SUPPLIERS, SUEZ

European equities are set to open higher after yesterday’s fall as a strong survey from
China propped up risk sentiment across Europe.

Apple suppliers look poised to gain on report that the world's largest company has
asked suppliers to make at least 75 million 5G iPhones for later this year. Dialog Semi
, STMicro, Infineon and other European chipmakers under spotlight.

Encouraging news on the coronavirus front as AstraZeneca, which is working with
Oxford University researchers, and Pfizer with partner BioNTech, said they
could have data by October to support U.S. emergency use authorization or approval of their
vaccines.

Meanwhile, Sanofi shares could come under pressure after the French pharma major
said its Kevzara drug trial didn't meet main goal in Covid-19 study.

In other key French moves, Suez, which saw its shares rise around 25% after
yesterday’s Veolia offer, said an unsolicited takeover approach carried "great
uncertainties" and it reiterated its confidence as an independent company.

Vivendi and activist fund Amber Capital - the two biggest shareholders in French
company Lagardere - said they would go to court over Lagardere's refusal to hold a
special shareholders meeting.

Roche received approval from the United States Food and Drug Administration for its
Cobas qualitative testing systems to confirm HIV diagnosis.

Apple suppliers

Seadrill proposed to creditors to turn over its stakes in oil services firms
Archer and Seadrill Seabras to redeem its outstanding secured notes.

Shares in Rocket Internet are up 2.6% in premarket trade after the company
announced a delisting plan.

(Stefano Rebaudo)

*****

MORNING CALL: IN THE BLACK BUT WITH VIRUS CONCERNS (0533 GMT)

European stock futures are in the black this morning along with their U.S. peers, but
concerns about the economic impact of the pandemic after the summer break are still in place.

China's factory activity which expanded at the fastest clip in nearly a decade in August,
bolstered by the first increase in new export orders this year, is supporting risk sentiment in
the continent after driving Asian shares in positive territory.

Expectations of long-lasting fiscal and monetary stimulus are also propping up equities, but
pandemic trajectories are expected to be the main investors focus in the fall, at least until a
vaccine is at hand.

(Stefano Rebaudo)

*****

More News
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.